Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diagnostic testing fails the test.

Literature DB >> 11832913

Diagnostic testing fails the test.

Jon F Merz¹, Antigone G Kriss, Debra G B Leonard, Mildred K Cho.

Abstract

Keywords: Empirical Approach; Genetics and Reproduction; Health Care and Public Health

Mesh：

Year: 2002 PMID： 11832913 PMCID： PMC2220021 DOI： 10.1038/415577a

Source DB: PubMed Journal: Nature ISSN： 0028-0836 Impact factor: 49.962

× No keyword cloud information.

11 in total

1. Survey confirms fears about licensing of genetic tests.

Authors: A Schissel; J F Merz; M K Cho
Journal: Nature Date: 1999-11-11 Impact factor: 49.962

2. Detection of an unusual combination of mutations in the HFE gene for hemochromatosis.

Authors: K Thorstensen; A Asberg; M Kvitland; E Svaasand; K Hveem; K S Bjerve
Journal: Genet Test Date: 2000

3. Testing time for gene patent as Europe rebels.

Authors: M Wadman
Journal: Nature Date: 2001-10-04 Impact factor: 49.962

4. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors: J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal: Nat Genet Date: 1996-08 Impact factor: 38.330

5. Public-sector patents on human DNA.

Authors: S M Thomas; N Birtwistle; M Brady; J F Burke
Journal: Nature Date: 1997-08-21 Impact factor: 49.962

Review 6. Can patents deter innovation? The anticommons in biomedical research.

Authors: M A Heller; R S Eisenberg
Journal: Science Date: 1998-05-01 Impact factor: 47.728

7. Withholding research results in academic life science. Evidence from a national survey of faculty.

Authors: D Blumenthal; E G Campbell; M S Anderson; N Causino; K S Louis
Journal: JAMA Date: 1997-04-16 Impact factor: 56.272

8. Ownership of the human genome.

Authors: S M Thomas; A R Davies; S M Birtwistle; S M Crowther; J F Burke
Journal: Nature Date: 1996-04-04 Impact factor: 49.962

9. Disease gene patents: overcoming unethical constraints on clinical laboratory medicine.

Authors: J F Merz
Journal: Clin Chem Date: 1999-03 Impact factor: 8.327

Review 10. What's new in hemochromatosis.

Authors: P A Gochee; L W Powell
Journal: Curr Opin Hematol Date: 2001-03 Impact factor: 3.284

28 in total

1. Gene patents and the standard of care.

Authors: Richard Gold; Timothy A Caulfield; Peter N Ray
Journal: CMAJ Date: 2002-08-06 Impact factor: 8.262

2. Patenting of genetic material: are the benefits to society being realized?

Authors: Donald J Willison; Stuart M MacLeod
Journal: CMAJ Date: 2002-08-06 Impact factor: 8.262

3. The importance of being inventive. Critics claim that patents on genes may lead to very broad monopolies and inhibit further innovation. The European patent system provides efficient legal means to address these issues.

Authors: Berthold Rutz; Siobhán Yeats
Journal: EMBO Rep Date: 2004-02 Impact factor: 8.807

Diagnostic testing fails the test.

1. Survey confirms fears about licensing of genetic tests.

2. Detection of an unusual combination of mutations in the HFE gene for hemochromatosis.

3. Testing time for gene patent as Europe rebels.

4. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

5. Public-sector patents on human DNA.

Review 6. Can patents deter innovation? The anticommons in biomedical research.

7. Withholding research results in academic life science. Evidence from a national survey of faculty.

8. Ownership of the human genome.

9. Disease gene patents: overcoming unethical constraints on clinical laboratory medicine.

Review 10. What's new in hemochromatosis.

1. Gene patents and the standard of care.

2. Patenting of genetic material: are the benefits to society being realized?

3. The importance of being inventive. Critics claim that patents on genes may lead to very broad monopolies and inhibit further innovation. The European patent system provides efficient legal means to address these issues.

4. Effects of patents and licenses on the provision of clinical genetic testing services.

5. Ethico-legal issues in biomedicine patenting: a patent professional viewpoint.

6. Patenting genes.

7. Translating research into cancer molecular diagnostics and patents.

8. Evidence and anecdotes: an analysis of human gene patenting controversies.

9. HER2 testing: the patent "genee" is out of the bottle.

10. Harm, hype and evidence: ELSI research and policy guidance.